Effect of mitochondrial toxins on evoked somatosensory activity in rats
Tóm tắt
Mitochondrial toxins represent an interesting group of neurotoxicants related both to causation and modelling of central nervous damage. 3-nitropropionic acid (3NP), a neurotoxin of herbal and microfungal origin, inhibits succinate dehydrogenase leading thereby to various biochemical and morphological alterations in the brain. Experimental animals treated by 3NP are used to model Huntington’s disease. Manganese, often present in occupational settings and as environmental pollutant, inhibits complex II and III of the mitochondria and is known to cause Parkinson-like CNS damage. In this work, rats were administered a single acute dose of Mn (50 mg Mn2+/kg body weight) or 3-NP (20 mg/kg b.w.) and the alterations of the somatosensory cortical evoked potential elicited by stimulation of the whisker pad and the tail base were observed, together with the changes of the action potential in the tail nerve. Latency and amplitude of the two cortical responses changed in parallel, while those of the tail nerve response remained more or less unaltered. The two mitochondrial toxins studied seem to exert their action centrally, primarily on synaptic transmission, rather than peripherally. Recording of evoked activity could be used to follow-up the nervous system effects of mitochondrial toxins, but it requires further investigation.
Tài liệu tham khảo
Montirosso R., Brambilla D., Felisari G., Sclaunich F., Filipponi E., Pozzoli U., et al., Electrophysiological analysis of cognitive slowing in subjects with mitochondrial encephalomyopathy, J. Neurol. Sci., 2002, 15, 3–9
Sciacco M., Prelle A., Comi G.P., Napoli L., Battistel A., Bresolin N., et al., Retrospective study of a large population of patients affected with mitochondrial disorders: clinical, morphological and molecular genetic evaluation, J. Neurol., 2001, 248, 778–788
Smith S.J., Harding A.E., EEG and evoked potential findings in mitochondrial myopathies, J. Neurol., 1993, 240, 367–372
ATSDR, Toxicological profile for manganese. US Department of Health and Human Services, 2000, Atlanta, GA USA
Dobson A.W., Erikson K.M, Aschner M., Manganese neurotoxicity, Ann. N.Y. Acad. Sci., 2004, 1012, 115–128
Brouillet E.P., Shinobu L., McGarvey U., Hochberg F., Beal M.F., Manganese injection into the rat striatum produces excitotoxic lesion by impairing energy metabolism, Exp. Neurol., 1993, 120, 89–94
Nelson M.T., Interactions of divalent cations with single calcium channels from rat brain synaptosomes, J. Gen. Physiol., 1986, 87, 201–222
Takeda A., Sotogaku N., Oku N., Influence of manganese on the release of neurotransmitters in rat striatum, Brain Res., 2003, 323, 31–46
Hazell A.S., Norenberg M.D., Manganese decreased glutamate uptake in cultured astrocytes, Neurochem. Res., 1997, 22, 1443–1447
Johnson J.R., Robinson B.L., Ali S.F., Binienda Z., Dopamine toxicity following long term exposure to low doses of 3-nitropropionic acid (3-NPA) in rats, Toxicol. Lett., 2000, 116, 113–118
Liu X., Luo X., Hu W., Studies on the epidemiology and etiology of moldy sugarcane poisoning in China, Biomed. Environ. Sci., 1992, 5, 161–177
Alexi T., Borlongan C.V., Faull R.L.M., Williams C.E., Clark R.G., Gluckmann P.D., et al., Neuroprotective strategies for basal ganglia degeneration: Parkinson’s and Huntington’s diseases, Prog. Neurobiol., 2000, 60, 409–470
Coles C.J., Edmondson D.E., Singer T.P., Inactivation of succinate dehydrogenase by 3-nitropropionate, J. Biol. Chem., 1979, 254, 5161–5167
Brouillet E., Conde F., Beal M.F., Hantraye P., Replicating Huntington’s disease phenotype in experimental animals, Prog. Neurobiol., 1999, 59, 427–468
Pubill D., Verdaguer E., Canudas A.M., Sureda F.X., Escubedo E., Camarasa J., et al., Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo, Br. J. Pharmacol., 2001, 132, 693–702
Szabó A., Pecze L., Papp A., Changes in the spontaneous and evoked cortical activity of rats induced by two different mitochondrial toxins, Centr. Eur. J. Occup. Envir. Med., 2004, 10, 5–11
Mook D., Anesthetic Management of Rodents and Rabbits., 2006, http://www.dar.emory.edu/vet_drug_anesthetic.htm#inj (11.12.2009)
Tracey D.J., Waite P.M., Somatosensory system, In: Paxinos G., (Ed.), The rat nervous system, Academic Press, San Diego, USA, 1995, 689–704
Pecze L., Papp A., Nagymajtényi L., Changes in the spontaneous and stimulus-evoked activity in the somatosensory cortex of rats on acute manganese administration, Toxicol. Lett., 2004, 148, 125–131
Szabó A., Papp A., Nagymajtényi L., Vezér T., Alterations in the cortical and peripheral somatosensory evoked activity of rats treated with 3-nitropropionic acid, Toxicol. Lett. 2006, 160, 212–217
Takács Sz., Bankó S, Papp A., Altered stimulus frequency and intensity dependence of the somatosensory evoked potential in rats after acute application of two mitochondrial toxins, Acta Biol. Szeged., 2009, 53, in press
Malecki E.A., Manganese toxicity is associated with mitochondrial dysfunction and DNA fragmention in rat primary striatal neurons, Brain Res. Bull., 2001, 55, 225–228
Zhang J., Fitsanakis V.A., Gu G., Jing D., Ao M., Amarnath V., et al., Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction, J. Neurochem., 2003, 84, 336–346
Tavares R.G., Santos C.E., Tasca C.I., Wajner M., Souza D.O., Dutra-Filho C.S., Inhibition of glutamate uptake into synaptic vesicles from rat brain by 3-nitropropionic acid in vitro, Exp. Neurol., 2001, 172, 250–254
Normandin L., Hazell A.S., Manganese neurotoxicity: an update of pathophysiologic mechanisms, Metab. Brain Dis., 2002, 17, 375–387
Vezér T., Papp A., Hoyk Z., Varga C., Náray M., Nagymajtényi L., Behavioral and neurotoxicological effects of subchronic manganese exposure in rats, Env. Toxicol. Pharmacol., 2005, 19, 797–810
Rosing H.S., Hopkins L.C., Wallace D.C., Epstein C.M., Weidenheim K., Maternally inherited mitochondrial myopathy and myoclonic epilepsy, Ann. Neurol., 1985, 17, 228–237